| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 2, 2024 | Jan 4, 2024 | Royalty Pharma plc | Director | Sell | 15.0 | -470,000 | -79.62% | ✗ | $13.2M |
| Sep 27, 2023 | Dec 14, 2023 | Cibus, Inc. | CEO | Buy | 100.0 | +477,631 | 21.23% | ✗ | $5.5M |
| May 31, 2023 | Jun 2, 2023 | Cibus, Inc. | CEO | Buy | 91.3 | +4,042,548 | 64.22% | ✗ | $31.5K |
| May 22, 2023 | May 22, 2023 | Royalty Pharma plc | Director | Sell | 15.0 | -1,750,000 | -94.24% | ✗ | $57.4M |
| Mar 29, 2023 | Mar 30, 2023 | Royalty Pharma plc | Director | Sell | 16.3 | -139,950 | -8.25% | ✗ | $5.1M |
| Dec 9, 2022 | Dec 13, 2022 | Royalty Pharma plc | Director | Sell | 17.5 | -60,000 | -15.24% | ✗ | $2.5M |
| Nov 17, 2022 | Nov 21, 2022 | Royalty Pharma plc | Director | Sell | 16.3 | -120,000 | -31.84% | ✗ | $5.1M |
| Sep 14, 2022 | Sep 15, 2022 | Royalty Pharma plc | Director | Sell | 17.5 | -100,000 | -20.97% | ✗ | $4.2M |
| Aug 9, 2022 | Aug 11, 2022 | Royalty Pharma plc | Director | Sell | 17.5 | -45,000 | -8.62% | ✗ | $2M |
| Jun 29, 2022 | Jun 29, 2022 | Royalty Pharma plc | Director | Sell | 17.5 | -30,000 | -5.44% | ✗ | $1.3M |
| May 19, 2022 | May 23, 2022 | Royalty Pharma plc | Director | Sell | 16.3 | -150,000 | -21.37% | ✗ | $5.9M |
| Mar 29, 2022 | Mar 30, 2022 | Royalty Pharma plc | Director | Sell | 17.5 | -60,000 | -7.88% | ✗ | $2.3M |
| Mar 17, 2022 | Mar 21, 2022 | Royalty Pharma plc | Director | Sell | 16.3 | -1,936,613 | -71.77% | ✗ | $6.7M |
| Dec 28, 2021 | Dec 30, 2021 | Royalty Pharma plc | Director | Sell | 16.3 | -1,404,650 | -34.23% | ✗ | $7.4M |
| Nov 16, 2021 | Nov 18, 2021 | Royalty Pharma plc | Director | Sell | 16.3 | -2,009,728 | -32.88% | ✗ | $9.1M |
| Sep 28, 2021 | Sep 30, 2021 | Royalty Pharma plc | Director | Sell | 17.5 | -1,048,578 | -14.64% | ✗ | $4.7M |
| Jun 25, 2021 | Jun 29, 2021 | Royalty Pharma plc | Director | Sell | 15.0 | -1,314,912 | -15.51% | ✗ | $55.4M |
| Jun 7, 2021 | Jun 8, 2021 | Royalty Pharma plc | Director | Buy | 95.0 | +273,650 | 3.34% | ✗ | $12.4M |
| Oct 20, 2020 | Oct 23, 2020 | Royalty Pharma plc | Director | Sell | 15.0 | -463,200 | -100.00% | ✗ | $19.5M |
| Oct 20, 2020 | Oct 22, 2020 | Royalty Pharma plc | Director | Sell | 15.0 | -463,200 | -96.86% | ✗ | $19.5M |
| Jun 18, 2020 | Jun 23, 2020 | Royalty Pharma plc | Director | Buy | 97.5 | +15,000 | 100.00% | ✗ | $420K |
| Mar 12, 2018 | Mar 14, 2018 | FIBROGEN INC | Director | Sell | 17.5 | -32,095 | -3.16% | ✗ | $1.8M |
| Mar 9, 2018 | Mar 9, 2018 | FIBROGEN INC | Director | Sell | 17.5 | -22,905 | -2.20% | ✗ | $1.3M |
| Sep 13, 2017 | Sep 15, 2017 | FIBROGEN INC | Director | Sell | 17.5 | -25,000 | -2.35% | ✗ | $1.3M |
| Dec 16, 2016 | Dec 16, 2016 | FIBROGEN INC | Director | Sell | 20.0 | -20,000 | -1.84% | ✗ | $417.3K |